Wellington Management Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMO
WA
BG
CS
EC
TCM
Wellington Management Group's SGMO Position: Q1 2020 in Review
Wellington Management Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2020, closing a stake of 7,746,382 shares — an estimated $64.8M sold.
Wellington Management Group first reported a position in SGMO in Q2 2013 and held it in 18 quarters. The position peaked at $119M in Q2 2019. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.
- Wellington Management Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2020 after selling out during the quarter.
- Wellington Management Group sold 7,746,382 SANGAMO THERAPEUTICS INC shares in Q1 2020, an estimated $64.8M.
- Wellington Management Group first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 18 quarters.
- Wellington Management Group's SANGAMO THERAPEUTICS INC position peaked at $119M in Q2 2019.
- 190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.
Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.